This Revolutionary Tech Fits in the Palm of Your Hand

Post a Comment
Turn Your Images On

This Revolutionary Tech Fits in the Palm of Your Hand

By Charles Mizrahi, Founder, Alpha Investor

Dear Real Talk Reader,

In high school, I failed chemistry and biology. 

So, if science isn’t your No. 1 subject, I feel you.

But even I’m seeing how much genome sequencing could impact people’s lives. 

It’s left my mouth hanging wide open. And you should feel the same way.

Because it’s already changing how you, me and our loved ones get medical treatment and live our lives.

Here’s how it works…

Building Blocks

Everybody has DNA. 

It’s the basic building block for your genes, which carry the information inherited from your parents and determine your traits. 

This includes everything from the color of your eyes to your height and even to whether your hair is curly or straight.

And a genome is the entire set of genes in a person. Genome sequencing maps out all of this genetic material.

Genomes are important because doctors can use them to look for variations or mutations in the DNA.

They can not only find the cause of existing medical conditions but catch diseases before people experience symptoms.

The technology that drives DNA sequencing is already helping us:

  • Detect and treat diseases — like cancer, Parkinson’s, Alzheimer’s and more — early.

  • Provide technology in the fight against COVID-19.

  • And diagnose intellectual and developmental delays in children.

And soon, doctors will be able to create personalized plans to treat major diseases, cancer or predict your health — all based on the exact genes in patients’ genomes. 

Ultimately, everyone will see a better quality of life.

You might be thinking that this technology costs a fortune to produce and distribute.

And that was true, back in the day…

Prices Slashed

In the early 2000s, the cost to sequence one person’s genome was nearly $100 million.

But that’s not the case anymore. You can now have your own genome sequenced for just $600.

And costs are heading even lower…

Turn Your Images On

Diagnosing and treating rare diseases is within reach. And once we start, we’ll see the benefits almost immediately.

Companies in the genomics space have already been quietly growing over the last four years.

They’ve been outperforming other biotech stocks and the entire health care industry.

And one company in particular is leading the way…

$40 Trillion in New Market Value

It’s set to disrupt EVERYTHING over the next decade: health care, agriculture, textiles, energy, data storage. All from ONE tech. What is it? Watch this video presentation for details.

Tiny Tech

Its piece of technology is no bigger than the palm of your hand.

Surprisingly, few people have heard of it.

But the few who have are saying it will disrupt the world.

In other words: It’ll affect every single person on Earth in one way or another.

So, I’ve put together a special video where I talk about this game-changing technology and the company that could help you profit from it. You can watch it right here.


Turn Your Images On
Charles Mizrahi
Founder, Alpha Investor

Turn Your Images On

Turn Your Images On

Turn Your Images On

Turn Your Images On

Listen to the Latest Episode of The Charles Mizrahi Show

Turn Your Images On

This Spinoff Rear-Ended the Used Car Market

Turn Your Images On

What Warren Buffett's $51 Billion Spending Spree Means for You

Turn Your Images On

Why 7 Billionaires Are Piling Into This Stock

We're on Social Media! Be Sure to Follow Us…

Turn Your Images On  Turn Your Images On  Turn Your Images On

Privacy Policy
Real Talk With Charles Mizrahi, P.O. Box 8378, Delray Beach, FL 33482.

To ensure that you receive future issues of Real Talk With Charles Mizrahi, please add info@mb.banyanhill.com to your address book or whitelist within your spam settings. For customer service questions or issues, please contact us for assistance.

The mailbox associated with this email address is not monitored, so please do not reply. Your feedback is very important to us so if you would like to contact us with a question or comment, please click here: http://banyanhill.com/contact-us

Legal Notice: This work is based on what we've learned as financial journalists. It may contain errors and you should not base investment decisions solely on what you read here. It's your money and your responsibility. Nothing herein should be considered personalized investment advice. Although our employees may answer general customer service questions, they are not licensed to address your particular investment situation. Our track record is based on hypothetical results and may not reflect the same results as actual trades. Likewise, past performance is no guarantee of future returns. Certain investments carry large potential rewards but also large potential risk. Don't trade in these markets with money you can't afford to lose. Banyan Hill Publishing expressly forbids its writers from having a financial interest in their own securities or commodities recommendations to readers. Such recommendations may be traded, however, by other editors, Banyan Hill Publishing, its affiliated entities, employees, and agents, but only after waiting 24 hours after an internet broadcast or 72 hours after a publication only circulated through the mail.

(c) 2022 Banyan Hill Publishing. All Rights Reserved. Protected by copyright laws of the United States and treaties. This Newsletter may only be used pursuant to the subscription agreement. Any reproduction, copying, or redistribution, (electronic or otherwise) in whole or in part, is strictly prohibited without the express written permission of Banyan Hill Publishing. P.O. Box 8378, Delray Beach, FL 33482. (TEL: 866-584-4096)

Remove your email from this list: Click here to Unsubscribe

Related Posts

There is no other posts in this category.

Post a Comment

Subscribe Our Newsletter